NCT00109486View on ClinicalTrials.gov

Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Rhinitis, Allergic, Perennial and Seasonal
Interventions
DRUG

GW685698X

Trial Locations (1)

8900

GSK Investigational Site, Randers

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00109486 - Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray | Biotech Hunter | Biotech Hunter